Author

Yueyi Sun

h-index 1 View on Semantic Scholar

We have 1 of 6 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Enlicitide: The first oral PCSK9 inhibitor approved for treatment of hypercholesterolemia.

The ongoing CORALreef Outcomes trial will determine whether enlicitide-mediated LDL-C reduction translates into fewer major cardiovascular events and will help define its long-term clinical role.

Yueyi Sun, Jianjun Gao · Drug Discoveries & Therapeut... · 0 citations